These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 9072836

  • 1. [Cefoperazone in the treatment of infections of the gallbladder, biliary ducts and liver in surgical patients].
    Vyhnánek F, Lochman O, Pelák Z.
    Rozhl Chir; 1996 Nov; 75(11):544-8. PubMed ID: 9072836
    [Abstract] [Full Text] [Related]

  • 2. [Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)].
    Hirasawa S, Abe H, Bekki E, Hashimoto I, Sawada Y, Nakamura T, Mikami J, Watanabe Y.
    Jpn J Antibiot; 1980 Dec; 33(12):1294-300. PubMed ID: 6454012
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy and safety of sulbactam/cefoperazone for hepato-biliary infections].
    Shinagawa N, Takeda S, Oohira S, Yasuda Y, Fujisaki M, Saito H, Ueda M, Mitamura K, Nishio T, Itakura M, Koyama M, Hirano M, Ohyama R, Kako M, Amako Y, Okuda K, Iwasa T, Sugiyama A, Hirano M, Takashima S, Ohswawa N, Nakaya S, Yamada M, Zeze F, Ishii J.
    Jpn J Antibiot; 1997 Nov; 50(11):862-70. PubMed ID: 9651604
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Penetration of ceftriaxone and cefoperazone into bile and gallbladder tissue in patients with acute cholecystitis.
    Orda R, Berger SA, Levy Y, Shnaker A, Gorea A.
    Dig Dis Sci; 1992 Nov; 37(11):1691-3. PubMed ID: 1425067
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Antibacterial prevention of complications in the surgical treatment of inflammatory diseases of the biliary tract].
    Arik'iants MS, Tyshko AG, Radzikhovskiĭ AP.
    Klin Khir (1962); 1987 Nov; (9):9-11. PubMed ID: 3695204
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Biliary excretion and clinical evaluation of cefoperazone in the biliary tract infections].
    Koizumi M, Simosegawa T, Yanbe M, Goto Y, Sugawara H, Kanno Y, Kanazawa Y, Kai Y, Sato T, Endou K.
    Jpn J Antibiot; 1986 Jul; 39(7):1663-70. PubMed ID: 3773263
    [Abstract] [Full Text] [Related]

  • 12. [Clinical studies on 6059-S for biliary tract diseases. Clinical effect and tissue concentration (author's transl)].
    Abe H, Hirasawa S, Bekki E, Sawada Y, Hashimoto I, Nakamura T, Mikami J, Katoh H, Matsuda S.
    Jpn J Antibiot; 1981 Apr; 34(4):631-40. PubMed ID: 6457172
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative study of ceftriaxone and cefoperazone in the treatment of acute cholecystitis.
    Friedlender J, Meyer P, Marti MC, Rohner A.
    Chemotherapy; 1988 Apr; 34 Suppl 1():30-3. PubMed ID: 3246168
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cefazolin in the treatment of biliary tract infections.
    Paulet P.
    Acta Gastroenterol Belg; 1976 Apr; 39(7-8):293-7. PubMed ID: 1015201
    [No Abstract] [Full Text] [Related]

  • 18. [Chemotherapy for biliary tract infection (XXXIII). Tissue concentration of NY-198 in gallbladder, biliary excretion and clinical effects].
    Tanimura H, Aoki Y, Uesaka K, Kasano Y, Nakai T, Kitamura T, Mukaihara S, Tamura K, Yotsumoto F, Terao R.
    Nihon Geka Hokan; 1988 Sep 01; 57(5):381-99. PubMed ID: 3251425
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical studies of BRL 28500 (clavulanic acid/ticarcillin) in the treatment of intraperitoneal infections and biliary tract infections].
    Sakai K, Ueda T, Uchino J, Hayasaka A, Shiramatsu K, Nagamachi Y, Shoda Y, Okui K, Hayata Y, Watanabe H.
    Jpn J Antibiot; 1987 Apr 01; 40(4):759-811. PubMed ID: 3302345
    [Abstract] [Full Text] [Related]

  • 20. [Gram-negative hepatobiliary infections].
    Bernuau J, Rueff B.
    Rev Prat; 1983 Jan 11; 33(3):107-12. PubMed ID: 6844819
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.